RCEL Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PARDAVIMAS 113940 min ago

@ $17.14

Išleistas: 13 vas. 2024 @ 22:41

Grąža: -49.12%

Ankstesnis signalas: vas. 12 - 20:54

Ankstesnis signalas: Pirkimas

Grąža: 0.06 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	184 344
Vidutinė apimtis	238 642
Rinkos kapitalizacija	224.97M
EPS	$0 ( 2024-02-22 )
Kita pelno data	( $-0.260 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.23
ATR14	$0.0180 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	O'toole David D	Buy	250	Common Stock
2024-02-28	O'toole David D	Buy	1 000	Common Stock
2024-01-03	Shiroma Donna	Buy	100 000	Stock Options (Right to Buy)
2023-11-30	Shiroma Donna	Buy	1 469	Common Stock
2024-01-03	O'toole David D	Buy	125 000	Stock Options (Right to Buy)

INSIDER POWER
72.79
Last 97 transactions
Buy: 1 597 984 \| Sell: 352 272

Tūris Koreliacija

Ilgas: -0.06 (neutral)

Trumpas: -0.18 (neutral)

Signal:(53.801) Neutral

Avita Therapeutics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
LWAC	0.956
NSIT	0.948
SJ	0.935
SRAC	0.93
MCAA	0.929
AMRB	0.929
TZPS	0.927
USAP	0.924
COCO	0.923
BIOT	0.922

10 Labiausiai neigiamai susiję koreliacijos
SVAC	-0.949
FRBK	-0.94
AROW	-0.937
BCBP	-0.93
BWB	-0.926
GSMG	-0.921
DSWL	-0.92
ESPR	-0.919
VGFC	-0.918
FVCB	-0.917

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Avita Therapeutics Inc Koreliacija - Valiuta/Žaliavos

0.70
( moderate )

0.61
( weak )

0.00
( neutral )

0.69
( moderate )

-0.10
( neutral )

-0.77
( moderate negative )

Avita Therapeutics Inc Finansinės ataskaitos

Annual	2022
Pajamos:	$34.42M
Bruto pelnas:	$28.38M (82.45 %)
EPS:	$-1.070

FY	2022
Pajamos:	$34.42M
Bruto pelnas:	$28.38M (82.45 %)
EPS:	$-1.070

FY	2021
Pajamos:	$29.23M
Bruto pelnas:	$23.28M (79.65 %)
EPS:	$-1.170

FY	2020
Pajamos:	$14.26M
Bruto pelnas:	$11.29M (79.16 %)
EPS:	$-2.07

Financial Reports:

No articles found.

Avita Therapeutics Inc

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.